Imatge de la portada

Immunotherapy in Myeloma

Immunotherapy in multiple myeloma, first investigated with allogeneic stem cell transplantation, is now a major pillar in the treatment of multiple myeloma. CAR-T-cell technology, monoclonal or bispecific antibodies, as well as new forms of cellular therapy, have revolutionized the treatment of this...

Descripció completa

Guardat en:
Format: Online
Idioma:anglès
Publicat: MDPI - Multidisciplinary Digital Publishing Institute 2022
Matèries:
multiple myeloma
immunotherapy
daratumumab
BCMA
bi-specific T cell engagers
chimeric antigen receptor
relapse
cytokine-release syndrome
allogeneic transplantation
myeloablative
non-myeloablative
new drugs
CAR T
antibodies
monoclonal
bispecific
immunoconjugates
antibody-drug conjugates
myeloma
NK cells
immunomodulation
cell therapy
graft-versus-myeloma
donor lymphocyte infusion
allogeneic stem cell transplantation
prophylaxis
salvage
CAR T-cells
target antigen
n/a
thema EDItEUR::M Medicine and Nursing
Accés en línia:ONIX_20220224_9783036529073_75
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Internet

ONIX_20220224_9783036529073_75

Ítems similars